Home > Quotes > LLY

Eli Lilly and Company Common Stock Quote & Summary Data

LLY 
$75.53
*  
0.93
1.22%
Get LLY Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Eli Lilly and Company Common Stock Intraday Chart




News for LLY

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 76.51 $ 92.85
Low $ 75.10 $ 67.88

The current last sale of $75.53 is 11.27% Higher thanthe 52 week low.

P/E Ratio

ETFs with LLY as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
6.29% iShares U.S. Pharmaceutical ETF (IHE) -16.43 (-10.31%)
5.4% PowerShares Dynamic Pharmaceuticals (PJP) -8.23 (-11.47%)
4.25% SPDR S&P Pharmaceuticals ETF (XPH) -10.04 (-18.96%)
1.88% Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH) +1.69 (1.14%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Eli Lilly and Company (the "company" or "registrant" or "Lilly") was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and market products in two business segments--human pharmaceutical products and animal health products. The mission of our human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Our vision is to make a significant contribution to humanity by improving global health in the 21st century. Most of the products we sell today were discovered or developed by our own scientists, and our success depends to a great extent on our ability to continue to discover, develop, and bring to market innovative new medicines. Our animal health business, operating through our Elanco division, develops, manufactures, and markets products for both food animals and companion animals.  ... More ...  

Risk Grade

Where does LLY fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?